5-79619734-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001114394.3(TENT2):āc.86T>Gā(p.Val29Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00019 in 1,613,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001114394.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TENT2 | NM_001114394.3 | c.86T>G | p.Val29Gly | missense_variant | 2/15 | ENST00000453514.6 | NP_001107866.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TENT2 | ENST00000453514.6 | c.86T>G | p.Val29Gly | missense_variant | 2/15 | 5 | NM_001114394.3 | ENSP00000397563 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251274Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135796
GnomAD4 exome AF: 0.000194 AC: 283AN: 1461600Hom.: 0 Cov.: 30 AF XY: 0.000176 AC XY: 128AN XY: 727108
GnomAD4 genome AF: 0.000151 AC: 23AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.86T>G (p.V29G) alteration is located in exon 2 (coding exon 1) of the PAPD4 gene. This alteration results from a T to G substitution at nucleotide position 86, causing the valine (V) at amino acid position 29 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at